WallStSmart
AIDX

20/20 Biolabs, Inc. Common Stock

NASDAQ: AIDX · HEALTHCARE · MEDICAL DEVICES

$0.20
+0.25% today

Updated 2026-11-13

Market cap
$2.62M
P/E ratio
—
P/S ratio
1.29x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$0 – $50
Volume
0.1M

20/20 Biolabs, Inc. Common Stock (AIDX) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$0.20
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—

Financial forecast

Metric20212022202320242025
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B
EPS—————
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -285.00%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.